PL364906A1 - Wzmocnienie regeneracji komórkowej i/lub różnicowania komórkowego przy użyciu nie-metabolizującego cukru i polimerycznego absorbentu - Google Patents

Wzmocnienie regeneracji komórkowej i/lub różnicowania komórkowego przy użyciu nie-metabolizującego cukru i polimerycznego absorbentu

Info

Publication number
PL364906A1
PL364906A1 PL02364906A PL36490602A PL364906A1 PL 364906 A1 PL364906 A1 PL 364906A1 PL 02364906 A PL02364906 A PL 02364906A PL 36490602 A PL36490602 A PL 36490602A PL 364906 A1 PL364906 A1 PL 364906A1
Authority
PL
Poland
Prior art keywords
polymeric absorbent
metabolizable sugar
cell
cell differentiation
promoting
Prior art date
Application number
PL02364906A
Other languages
English (en)
Other versions
PL205732B1 (pl
Inventor
Daniel Jean
Leon Cariel
Veroniqe Schwaab
Original Assignee
Lmd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8859024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL364906(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lmd filed Critical Lmd
Publication of PL364906A1 publication Critical patent/PL364906A1/pl
Publication of PL205732B1 publication Critical patent/PL205732B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cosmetics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL364906A 2001-01-19 2002-01-21 Zastosowanie połączenia polimerowego absorbenta i niemetabolizującego cukru do wytwarzania kompozycji leczniczej i/lub kompozycji do stosowania w laboratoriach do traktowania kultur komórkowych PL205732B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0100738A FR2819721B1 (fr) 2001-01-19 2001-01-19 Traitement des escarres avec sucre non metabolisable et un absorbant polymerique
PCT/FR2002/000228 WO2002056894A1 (fr) 2001-01-19 2002-01-21 Favorisation de la reconstruction cellulaire et/ou de la differenciation cellulaire avec sucre non metabolisable et un absorbant polymerique

Publications (2)

Publication Number Publication Date
PL364906A1 true PL364906A1 (pl) 2004-12-27
PL205732B1 PL205732B1 (pl) 2010-05-31

Family

ID=8859024

Family Applications (1)

Application Number Title Priority Date Filing Date
PL364906A PL205732B1 (pl) 2001-01-19 2002-01-21 Zastosowanie połączenia polimerowego absorbenta i niemetabolizującego cukru do wytwarzania kompozycji leczniczej i/lub kompozycji do stosowania w laboratoriach do traktowania kultur komórkowych

Country Status (18)

Country Link
US (1) US20050191354A1 (pl)
EP (1) EP1351694B2 (pl)
JP (1) JP2004523521A (pl)
KR (1) KR20040018330A (pl)
AT (1) ATE372775T1 (pl)
CA (1) CA2434608C (pl)
CZ (1) CZ305405B6 (pl)
DE (1) DE60222377T3 (pl)
DK (1) DK1351694T4 (pl)
ES (1) ES2292711T5 (pl)
FR (1) FR2819721B1 (pl)
HU (1) HUP0302816A2 (pl)
MX (1) MXPA03006465A (pl)
PL (1) PL205732B1 (pl)
PT (1) PT1351694E (pl)
SI (1) SI1351694T2 (pl)
SK (1) SK9262003A3 (pl)
WO (1) WO2002056894A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148101A1 (en) * 1999-01-23 2005-07-07 Bamdad Cynthia C. Interaction of colloid-immobilized species with species on non-colloidal structures
US9314014B2 (en) * 2004-02-18 2016-04-19 University Of Maryland, Baltimore Compositions and methods for the storage of red blood cells
CA2607912A1 (en) * 2005-05-13 2006-11-16 Netech Inc. Medical composition for promotion of skin regeneration
US7294350B2 (en) * 2006-03-21 2007-11-13 Marraccini Philip A Healing powder and method of use thereof
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969498A (en) * 1973-09-13 1976-07-13 University Of The Pacific Dressing and method for treating a wound
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
JPH01203325A (ja) * 1988-02-08 1989-08-16 Takeda Chem Ind Ltd 骨粗鬆症予防治療剤
FR2645741B1 (fr) † 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
US5177065A (en) * 1990-12-26 1993-01-05 Silvetti Sr Anthony N Monosaccharide containing wound healing preparation
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
RU2150942C1 (ru) * 1993-10-01 2000-06-20 Синтекс (Ю.ЭС.ЭЙ.) Инк. Оральные суспензии, содержащие высокие дозы мофетила микофенолята
US5722942A (en) * 1994-02-18 1998-03-03 Kanebo, Ltd. Wound covering materials
US5801116A (en) * 1995-04-07 1998-09-01 Rhodia Inc. Process for producing polysaccharides and their use as absorbent materials
FR2736835B1 (fr) * 1995-07-17 1997-10-10 Aber Technologies Pansement pour plaies chroniques, notamment escarres, en gel de chitine
BR9701968A (pt) * 1997-04-30 1998-12-15 Unilever Nv Composição sinérgica contendo ingredientes umidificantes e absorventes filme ou máscara facial e tratamento facial
JP2854857B2 (ja) * 1997-06-04 1999-02-10 財団法人韓国科学技術研究院 キトサン又は改質キトサンが塗布された白血球除去用フィルタ
JP3472442B2 (ja) * 1997-06-05 2003-12-02 東亜薬品株式会社 損傷皮膚修復用製剤
JP2000038342A (ja) * 1998-05-18 2000-02-08 Kyowa Yakuhin Kogyo Kk 褥瘡・損傷皮膚修復用製剤

Also Published As

Publication number Publication date
US20050191354A1 (en) 2005-09-01
DE60222377T3 (de) 2012-01-26
FR2819721B1 (fr) 2005-02-04
DE60222377T2 (de) 2008-06-19
SI1351694T2 (sl) 2011-11-30
DK1351694T4 (da) 2011-11-14
ATE372775T1 (de) 2007-09-15
DE60222377D1 (de) 2007-10-25
EP1351694A1 (fr) 2003-10-15
DK1351694T3 (da) 2008-01-14
FR2819721A1 (fr) 2002-07-26
MXPA03006465A (es) 2004-10-15
EP1351694B1 (fr) 2007-09-12
PL205732B1 (pl) 2010-05-31
CZ20032011A3 (cs) 2004-02-18
HUP0302816A2 (hu) 2003-11-28
ES2292711T3 (es) 2008-03-16
KR20040018330A (ko) 2004-03-03
SI1351694T1 (sl) 2008-02-29
ES2292711T5 (es) 2011-12-01
PT1351694E (pt) 2007-12-20
SK9262003A3 (en) 2004-05-04
CZ305405B6 (cs) 2015-09-02
CA2434608C (fr) 2010-10-26
EP1351694B2 (fr) 2011-07-27
CA2434608A1 (fr) 2002-07-25
JP2004523521A (ja) 2004-08-05
WO2002056894A1 (fr) 2002-07-25

Similar Documents

Publication Publication Date Title
MXPA03005454A (es) Estructura absorbente delgada, de alta capacidad y metodo para producir la misma.
HUP0301823A3 (en) Sorbent composition, process for producing same and use in desulfurization
HUP0301826A3 (en) Sorbent composition, process for producing same and use in desulfurization
ZA993444B (en) Drive with high output in failed mode.
HK1058319A1 (en) Carrier with solid fibrinogen and solid thrombin.
GB9811082D0 (en) Improvements in phase-separation etc.members
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
EP1153942A4 (en) POLYMER, PROCESS FOR PRODUCING POLYMER, AND COMPOSITION
EP1317007A4 (en) METHOD AND DEVICE FOR PRODUCING ELECTRODE PLATES FOR CELLS AND CELL USING THESE ELECTRODE PLATES
MXPA01011516A (es) Incinerador de pared radiante de bajo nox.
AU5288599A (en) Disubstituted bicyclic heterocycles having, in particular, thrombin inhibitiveeffect
EP1167029A4 (en) PRINTING PLATE, AND PRINTING METHOD BASED ON THIS PLATE
GB2338244B (en) A microbe composition, a method to prepare the same and uses thereof
HK1022379A1 (en) Electrochemical device.
AU742455C (en) Interleaving method and device, and deinterleaving method and device
MXPA03009167A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
IL156050A0 (en) Porous polymeric biomaterials, preparation method and uses
MXPA01010764A (es) Ensamble de quemador de emisiones bajas en nox y metodo para reducir el contenido de nox de gas de combustion de alto horno.
MXPA02005128A (es) Articulos absorbentes adaptables.
MXPA03009204A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
HK1047503A1 (en) Sealing plate, cell using the sealing plate, and method of manufacturing the cell.
SI1351694T2 (sl) Pospeševanje celične regeneracije in/ali celične diferenciacije z nepresnovljivim sladkorjem in polimernim absorbentom
DE59902921D1 (en) Substituierte alpha,beta-anellierte butyrolactone
ZA200209104B (en) Method for detecting growth hormone variations in humans, the variations and their uses.
ITRM990493A0 (it) Dispositivo di comando manuale, in particolare per l'accelerazione.